Toulouse, France

Yves Génisson

This inventor holds 1 USPTO granted patent. Top assignee: Aventis Pharma S.a.. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yves Génisson. Retrieved from https://idiyas.com/inventor/yves-gandeacutenisson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yves Génisson: Innovator in Pharmaceutical Chemistry

Introduction

Yves Génisson is a notable inventor based in Toulouse, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the synthesis of important compounds.

Latest Patents

Yves Génisson holds a patent for the "Preparation of camptothecin and of its derivatives." This invention relates to a novel process for the preparation of camptothecin and its derivatives through convergent synthesis. The process starts from a 3-(aminomethyl)quinoline derivative and 5-hydroxy-5-ethyl-6-oxo-5,6-dihydropyrancarboxylic acid, leading to valuable intermediates.

Career Highlights

He is currently associated with Aventis Pharma S.A., where he continues to work on innovative solutions in the pharmaceutical industry. His expertise in the field has been instrumental in advancing research and development efforts.

Collaborations

Yves has collaborated with notable colleagues, including Stéphanie Garçon and Patrick Léon, contributing to various projects that enhance the understanding and application of pharmaceutical compounds.

Conclusion

Yves Génisson's work exemplifies the impact of innovative thinking in pharmaceutical chemistry, and his contributions continue to influence the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…